Protein Description

Gene Symbol POLR2L
Entrez ID 5441
Uniprot ID P62875
Description polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa
Chromosomal Location chr11: 837,356-842,545
Ontology GO ID GO Term Definition Evidence

BP

GO:0000398

mRNA splicing, via spliceosome

The joining together of exons from one or more primary transcripts of messenger RNA (mRNA) and the excision of intron sequences, via a spliceosomal mechanism, so that mRNA consisting only of the joined exons is produced.

TAS

BP

GO:0006283

transcription-coupled nucleotide-excision repair

The nucleotide-excision repair process that carries out preferential repair of DNA lesions on the actively transcribed strand of the DNA duplex. In addition, the transcription-coupled nucleotide-excision repair pathway is required for the recognition and repair of a small subset of lesions that are not recognized by the global genome nucleotide excision repair pathway.

TAS

BP

GO:0006356

regulation of transcription from RNA polymerase I promoter

Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase I promoter.

TAS

BP

GO:0006361

transcription initiation from RNA polymerase I promoter

Any process involved in the assembly of the RNA polymerase I preinitiation complex (PIC) at an RNA polymerase I promoter region of a DNA template, resulting in the subsequent synthesis of RNA from that promoter. The initiation phase includes PIC assembly and the formation of the first few bonds in the RNA chain, including abortive initiation, which occurs when the first few nucleotides are repeatedly synthesized and then released. Promoter clearance, or release, is the transition between the initiation and elongation phases of transcription.

TAS

BP

GO:0006362

transcription elongation from RNA polymerase I promoter

The extension of an RNA molecule after transcription initiation and promoter clearance at an RNA polymerase I specific promoter by the addition of ribonucleotides catalyzed by RNA polymerase I.

TAS

BP

GO:0006363

termination of RNA polymerase I transcription

The process in which the synthesis of an RNA molecule by RNA polymerase I using a DNA template is completed. RNAP I termination requires binding of a terminator protein so specific sequences downstream of the transcription unit.

TAS

BP

GO:0006366

transcription from RNA polymerase II promoter

The synthesis of RNA from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).

IDA|TAS

BP

GO:0006367

transcription initiation from RNA polymerase II promoter

Any process involved in the assembly of the RNA polymerase II preinitiation complex (PIC) at an RNA polymerase II promoter region of a DNA template, resulting in the subsequent synthesis of RNA from that promoter. The initiation phase includes PIC assembly and the formation of the first few bonds in the RNA chain, including abortive initiation, which occurs when the first few nucleotides are repeatedly synthesized and then released. Promoter clearance, or release, is the transition between the initiation and elongation phases of transcription.

TAS

BP

GO:0006368

transcription elongation from RNA polymerase II promoter

The extension of an RNA molecule after transcription initiation and promoter clearance at an RNA polymerase II promoter by the addition of ribonucleotides catalyzed by RNA polymerase II.

TAS

BP

GO:0006370

7-methylguanosine mRNA capping

Addition of the 7-methylguanosine cap to the 5' end of a nascent messenger RNA transcript.

TAS

BP

GO:0006383

transcription from RNA polymerase III promoter

The synthesis of RNA from a DNA template by RNA polymerase III, originating at an RNAP III promoter.

IEA

BP

GO:0008543

fibroblast growth factor receptor signaling pathway

The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.

TAS

BP

GO:0010467

gene expression

The process in which a gene's sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.

TAS

BP

GO:0031047

gene silencing by RNA

Any process in which RNA molecules inactivate expression of target genes.

TAS

BP

GO:0032481

positive regulation of type I interferon production

Any process that activates or increases the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.

TAS

BP

GO:0035019

somatic stem cell population maintenance

Any process by which an organism retains a population of somatic stem cells, undifferentiated cells in the embryo or adult which can undergo unlimited division and give rise to cell types of the body other than those of the germ-line.

TAS

BP

GO:0042795

snRNA transcription from RNA polymerase II promoter

The synthesis of small nuclear RNA (snRNA) from a DNA template by RNA Polymerase II (Pol II), originating at a Pol II promoter.

TAS

BP

GO:0045815

positive regulation of gene expression, epigenetic

Any epigenetic process that activates or increases the rate of gene expression.

TAS

BP

GO:0050434

positive regulation of viral transcription

Any process that activates or increases the frequency, rate or extent of viral transcription.

TAS

CC

GO:0005634

nucleus

A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

IDA

CC

GO:0005654

nucleoplasm

That part of the nuclear content other than the chromosomes or the nucleolus.

TAS

CC

GO:0005665

DNA-directed RNA polymerase II, core complex

RNA polymerase II, one of three nuclear DNA-directed RNA polymerases found in all eukaryotes, is a multisubunit complex; typically it produces mRNAs, snoRNAs, and some of the snRNAs. Two large subunits comprise the most conserved portion including the catalytic site and share similarity with other eukaryotic and bacterial multisubunit RNA polymerases. The largest subunit of RNA polymerase II contains an essential carboxyl-terminal domain (CTD) composed of a variable number of heptapeptide repeats (YSPTSPS). The remainder of the complex is composed of smaller subunits (generally ten or more), some of which are also found in RNA polymerases I and III. Although the core is competent to mediate ribonucleic acid synthesis, it requires additional factors to select the appropriate template.

IDA

CC

GO:0005666

DNA-directed RNA polymerase III complex

RNA polymerase III, one of three nuclear DNA-directed RNA polymerases found in all eukaryotes, is a multisubunit complex; typically it produces 5S rRNA, tRNAs and some of the small nuclear RNAs. Two large subunits comprise the most conserved portion including the catalytic site and share similarity with other eukaryotic and bacterial multisubunit RNA polymerases. The remainder of the complex is composed of smaller subunits (generally ten or more), some of which are also found in RNA polymerase I and others of which are also found in RNA polymerases I and II. Although the core is competent to mediate ribonucleic acid synthesis, it requires additional factors to select the appropriate template.

IBA

CC

GO:0005736

DNA-directed RNA polymerase I complex

RNA polymerase I, one of three nuclear DNA-directed RNA polymerases found in all eukaryotes, is a multisubunit complex; typically it produces rRNAs. Two large subunits comprise the most conserved portion including the catalytic site and share similarity with other eukaryotic and bacterial multisubunit RNA polymerases. The remainder of the complex is composed of smaller subunits (generally ten or more), some of which are also found in RNA polymerase III and others of which are also found in RNA polymerases II and III. Although the core is competent to mediate ribonucleic acid synthesis, it requires additional factors to select the appropriate template.

IBA

CC

GO:0005829

cytosol

The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.

TAS

MF

GO:0001054

RNA polymerase I activity

Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1). Utilizes a DNA template that contains an RNA polymerase I specific promoter to direct initiation and catalyzes DNA-template-directed extension of the 3'-end of an RNA strand by one nucleotide at a time. Can initiate a chain 'de novo'.

IBA

MF

GO:0001055

RNA polymerase II activity

Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1). Utilizes a DNA template that contains an RNA polymerase II specific promoter to direct initiation and catalyses DNA-template-directed extension of the 3'-end of an RNA strand by one nucleotide at a time. Can initiate a chain 'de novo'.

IBA

MF

GO:0001056

RNA polymerase III activity

Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1). Utilizes a DNA template that contains an RNA polymerase III specific promoter to direct initiation and catalyses DNA-template-directed extension of the 3'-end of an RNA strand by one nucleotide at a time. Can initiate a chain 'de novo'.

IBA

MF

GO:0003677

DNA binding

Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).

IEA

MF

GO:0003899

DNA-directed RNA polymerase activity

Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1). Utilizes a DNA template, i.e. the catalysis of DNA-template-directed extension of the 3'-end of an RNA strand by one nucleotide at a time. Can initiate a chain 'de novo'.

TAS

MF

GO:0008270

zinc ion binding

Interacting selectively and non-covalently with zinc (Zn) ions.

IBA

Domain ID Description

IPR000268

DNA-directed RNA polymerase, subunit N/Rpb10

IPR020789

RNA polymerases, subunit N, zinc binding site

IPR023580

RNA polymerase subunit RPB10

Pathway ID Pathway Term Pathway Source

hsa00230

Purine metabolism

KEGG

hsa00240

Pyrimidine metabolism

KEGG

hsa01100

Metabolic pathways

KEGG

hsa03020

RNA polymerase

KEGG

hsa04623

Cytosolic DNA-sensing pathway

KEGG

hsa05016

Huntington's disease

KEGG

hsa05169

Epstein-Barr virus infection

KEGG

No diseases found.

No tissues found.

No databases found.

Pubmed ID Author Year Title

22951915

Haozi et al.

2012

Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome

Gene Symbol Entrez ID Uniprot ID Score

POLR3H

171568

Q9Y535

0.00

POLR2I

5438

P36954

0.56

POLR1D

51082

Q9Y2S0

0.56

POLR3D

661

P05423

0.63

REL

5966

Q04864

0.63

TP53BP2

7159

Q13625

0.63

ZBTB14

7541

O43829

0.63

SPAG5

10615

Q96R06

0.63

CHEK2

11200

O96017

0.63

RPAP1

26015

Q9BWH6

0.63

SNX7

51375

Q9UNH6

0.63

BANP

54971

Q8N9N5

0.63

THAP1

55145

Q9NVV9

0.63

L3MBTL3

84456

Q96JM7

0.63

NFKBIB

4793

Q15653

0.73

COIL

8161

P38432

0.73

CCDC85B

11007

Q15834

0.73

POLR2G

5436

P62487

0.95

POLR3C

10623

Q9BUI4

0.49

ESR1

2099

P03372

0.52

PSMB9

5698

P28065

0.52

SRC

6714

P12931

0.52

TCEB3

6924

Q14241

0.52

SMARCD1

6602

Q96GM5

0.56

IMP3

55272

Q9NV31

0.56

POLR1B

84172

Q9H9Y6

0.56

POLR1C

9533

O15160

0.58

POLR1E

64425

Q9GZS1

0.59

PHC2

1912

Q8IXK0

0.63

NOV

4856

P48745

0.63

SKAP1

8631

Q86WV1

0.63

INTS6

26512

Q9UL03

0.63

GPN3

51184

Q9UHW5

0.63

GPN2

54707

Q9H9Y4

0.63

PIH1D1

55011

Q9NWS0

0.63

EXOSC5

56915

Q9NQT4

0.63

RPRD1B

58490

Q9NQG5

0.63

INTS5

80789

Q6P9B9

0.63

POLR2M

81488

Q6EEV4

0.63

SNCA

6622

P37840

0.72

MED28

80306

Q9H204

0.72

MED29

55588

Q9NX70

0.76

MED10

84246

Q9BTT4

0.76

SUPT5H

6829

O00267

0.79

POLR1A

25885

O95602

0.82

POLR2D

5433

O15514

0.86

MED26

9441

O95402

0.86

MED19

219541

A0JLT2

0.86

POLR2A

5430

P24928

0.92

POLR2B

5431

P30876

0.92

POLR2E

5434

P19388

0.92

POLR2H

5437

P52434

0.92

POLR2C

5432

P19387

0.95